002074 国轩高科
2025/03 - 三个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入9,055,22520.61%35,391,81731,605,49023,051,70110,356,081
减:营业总成本8,825,89719.89%34,519,14731,492,00623,008,49410,383,274
    其中:营业成本7,399,85618.09%29,020,13126,620,63118,949,6968,429,245
               财务费用346,45552.14%842,650547,493322,672335,245
               资产减值损失(33,260)359.67%(399,010)(244,369)(372,035)(197,742)
公允价值变动收益(54,473)-398.21%196,190105,891(139,874)(175)
投资收益54,770473.89%47,19468,685217,17614,414
    其中:对联营企业和合营企业的投资收益(933)-30.23%(85,206)(281)72,12427,582
营业利润102,662781.88%1,283,450975,425198,69439,046
利润总额99,257787.43%1,263,110948,160258,96447,719
减:所得税费用(2,785)-88.86%108,976(20,939)(106,676)(29,092)
净利润102,042182.02%1,154,134969,099365,64076,810
减:非控股权益1,409-104.28%(52,656)30,37254,064(24,964)
股东净利润100,63345.55%1,206,790938,727311,576101,774

市场价值指针
每股收益 (元) *0.06050.00%0.6800.5300.1800.080
每股派息 (元) *----0.1000.100--0.100
每股净资产 (元) *14.3764.72%14.40614.04213.21711.280
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容